Insiders · BHVN

Elyse Stock

Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Elyse Stock has filed 5 insider reports with the SEC since November 2021, as officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). Elyse Stock made no open-market purchases or sales in the last 12 months. The latest filing, on October 4, 2022, reports sale back to the company at Biohaven Pharmaceutical Holding Co Ltd. (BHVN).

Filings
5
Companies
1
Bought on market
None
Sold on market
$3.04M

Companies where Elyse Stock is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Biohaven Pharmaceutical Holding Co Ltd. logo
BHVN
Biohaven Pharmaceutical Holding Co Ltd.
Officer0$3.04M$12.39Oct 4, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Elyse Stock with

Other insiders at the same companies

Questions about Elyse Stock

What is Elyse Stock's role at Biohaven Pharmaceutical Holding Co Ltd.?
Elyse Stock reports to the SEC as officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), according to the latest filing on October 4, 2022.
Has Elyse Stock bought or sold stock recently?
The most recent open-market sale was on December 15, 2021: sold 28,858 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN) for $3.04M at an average of $105.37.
How do I get alerts when Elyse Stock files?
Follow Elyse Stock on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Elyse Stock (SEC CIK 0001785732). Totals count each trade once, skipping amendments whose original is on file, from Nov 26, 2021 on. View on SEC EDGAR · Get this as JSON